Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-17
SponsorMemorial Sloan Kettering Cancer Center

About this trial

The purpose of this study is to see if there is a difference between the development of the brain (neurodevelopment) in children who have been treated for retinoblastoma with multiple anesthetic exposures, compared with brain development in children who have never had anesthesia.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 6 and < 17 years old

Disqualifiers

Diagnosis of any secondary disease associated with developmental delay

History of second cancer diagnosis

Legal Blindness

Past surgery of any type, with the exception of enucleation for retinoblastoma

Trial population

pediatric patients with retinoblastoma, between 6 and 16 years of age, at MSK.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V)

    Other intervention

    the WISC-V assessment produces a Full Scale IQ (FSIQ) used for primary power consideration in this study. The FSIQ is the most comprehensive global ability score on the WISC-V, and it has been conventionally reported and interpreted as an estimation of overall intellectual ability

  • California Verbal Learning Test, Children's Version

    Other intervention

    Used to assess verbal learning and memory in children and adolescents

  • Beery Developmental Test of Visual Motor Integration, 6th edition

    Other intervention

    Helps assess visual-motor skills in children and adults.

  • Grooved Pegboard Test

    Other intervention

    Measures dexterity

  • Behavior Assessment System for Children/Parent Report

    Other intervention

    The Behavior Assessment System for Children/Parent Report is a questionnaire that assesses the social-emotional and behavioral functioning (e.g., anxiety, depression, attention, hyperactivity, adaptability, leadership, social skills, etc.) in children between the ages of 2 and 22 years, and is available in English and Spanish.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Comparing scores in neuropsychological testing results

The primary outcome is based on the Wechsler Intelligence Scale for Children, 5th edition (WISC-V) measured at follow up. The 5 primary index scores on the WISC-V (Verbal Comprehension, Visual Spatial, Fluid Reasoning, Working Memory, and Processing Speed) are based on 10 subtests and represent intellectual functioning in different cognitive areas. Similar to the FSIQ, the primary index scores are on a standard score metric with a mean of 100 (SD=15). The WISC-V consists of 16 subtests; each subtest is based on a scaled score metric with a mean of 10 and standard deviation (SD) of 3. Performance on these domain-specific subtests will be summarized and analyzed similarly to the FSIQ.

Time frame
6 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.